Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04829175

Ethicon Pelvic Mesh Post Market Clinical Follow-up Registry

The objective of this post market, clinical registry is to evaluate the performance of the products of the TVT family of products or vaginal vault or uterine prolapse repair (with laparotomic or laparoscopic approach including robotic assisted) using either Gynemesh PS Mesh or Artisyn Mesh in women undergoing surgery for SUI and POP.

Recruiting

Interested in participating?

Request Info

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients who satisfy all of the following criteria will be considered eligible for enrollment in this registry:

SUI

  • Stress urinary incontinence symptoms
  • Urodynamic stress incontinence confirmed with urodynamic testing
  • Female patient ≥ 21 years of age
  • Desired surgical correction of SUI using synthetic pubo-urethral vaginal sling
  • Planned surgery for primary SUI
  • Patient able and willing to participate in follow-up
  • Patient or authorized representative has signed the approved Informed consent POP
  • Uterine or vaginal vault prolapse symptoms 2. Urodynamic testing (optional) 3. Female patient ≥ 21 years of age 4. Desired surgical correction of POP using synthetic mesh 5. Planned surgery for uterine or vaginal vault prolapse with or without concomitant SUI surgery 6. Patient able and willing to participate in follow-up 7. Patient or authorized representative has signed the approved Informed consent

Exclusion criteria

Patients meeting any of the following criteria will be considered not eligible for enrollment in this registry:

  • Physical or psychological condition which would impair registry participation or are unwilling or unable to participate in all required registry visits and are unable to complete the questionnaires
  • Any pre-operative or intra-operative findings identified by the surgeon that may preclude the use of registry products
  • History of previous synthetic, biologic or fascial sub-urethral sling (SUI) or pelvic mesh (POP)
  • Pregnancy or plans for future pregnancy
  • History of bleeding diathesis or current anti-coagulation therapy which cannot be suspended peri-operatively according to site's standard practice
  • Current genitourinary fistula or urethral diverticulum
  • Reversible cause of incontinence (i.e. drug effect) for SUI only
  • Severe vaginal atrophy
  • History of pelvic irradiation therapy
  • Contraindication to surgery

Treatment and study plan

Intervention

Device

There is no intervention, beyond necessary clinical care, in this registry. The surgical procedures being performed within the registry are identical to the surgical procedures patients would receive as part of SOC.

Primary outcomes

  1. Stress Urinary Incontinence(SUI)- Cough Stress Test(CST) Assessment Change

    Time frame: Post-surgery through registry completion, approximately 5-10 yrs

    Objective cure (success) approximately 5-10 years after surgery, defined as a negative standardized cough stress test (CST)

  2. Pelvic Organ Prolapse (POP)- Physical Examination with Pelvic Organ Prolapse Quantification (POP-Q) Assessment Change

    Time frame: Post-surgery through registry completion, approximately 5-10 yrs

    Objective cure (success) approximately 5-10 years after surgery, defined as the absence of prolapse beyond the hymen as determined by a physical examination with POP-Q

Secondary outcomes

  1. SUI: International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF)

    Time frame: Baseline and post-surgery through registry completion, approximately 10 yrs

  2. SUI: Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12)

    Time frame: Baseline and post-surgery through registry completion, approximately 10 yrs

  3. SUI: Patient Global Impression of Improvement questionnaire (PGI-I)

    Time frame: Post-surgery through registry completion, approximately 10 yrs

  4. SUI: Wong-Baker FACES Pain Rating Scale

    Time frame: Post-surgery through registry completion, approximately 10 yrs

    To assess pain on a scale from 0 (no pain) to 10 (worst pain) related to registry device or procedure

  5. POP: Pelvic Floor Distress Inventory (PFDI-20) Questionnaire

    Time frame: Baseline and post-surgery through registry completion, approximately 10 yrs

  6. POP: Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12)

    Time frame: Baseline and post-surgery through registry completion, approximately 10 yrs

  7. POP: Patient Global Impression of Improvement questionnaire (PGI-I)

    Time frame: Post-surgery through registry completion, approximately 10 yrs

  8. POP: Wong-Baker FACES Pain Rating Scale

    Time frame: Post-surgery through registry completion, approximately 10 yrs

    To assess pain on a scale from 0 (no pain) to 10 (worst pain) related to registry device or procedure (if applicable)

Study contacts

Contact information is provided by the study sponsor or research team.

Christine Romanowski

CONTACT

[email protected]

908-808-6219

Sponsors and collaborators

Lead sponsor

Ethicon, Inc.

Industry

Registry information

Official study title

A Long Term Prospective Observational Post Market Clinical Follow-Up (PMCF) Registry of Ethicon Gynecare Pelvic Mesh Products for The Treatment of Stress Urinary Incontinence and Pelvic Organ Prolapse

Important dates

Study start
2022
Primary completion
2033
Study completion
2038
First posted
Apr 2, 2021
Registry last updated
Jul 6, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.